Tracing a roadmap for vitamin B12 testing using the health technology assessment approach

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 6, 2014, Pages 767-777

  Ferraro, Simona ^a   Mozzi, Roberta ^a   Panteghini, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Biological variability; Biomarker; Cut off; Diagnosis; Traceability

Indexed keywords

COBALAMIN; CYANOCOBALAMIN;

CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; CYANOCOBALAMIN DEFICIENCY; DIAGNOSTIC ACCURACY; ETHICS; HEALTH CARE SYSTEM; HEMODIALYSIS PATIENT; HUMAN; IMMUNOASSAY; LABORATORY; MORBIDITY; MORTALITY; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL CHEMISTRY; EXPERT WITNESS; LITERATURE; PROCEDURES; STANDARDS;

CLINICAL CHEMISTRY TESTS; EXPERT TESTIMONY; HUMANS; REVIEW LITERATURE AS TOPIC; TECHNOLOGY ASSESSMENT, BIOMEDICAL; VITAMIN B 12;

EID: 84903595277     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0738     Document Type: Review

References (83)

1. Panteghini M. The future of Laboratory Medicine: understanding the new pressures. Clin Biochem Rev 2004;25:207-15
2. Dominici R, Dolci A, Valente C, Infusino I, Panteghini M. One-year audit of the implementation of protocols for optimal use of cardiac biomarkers in an Italian university hospital. Clin Chem Lab Med 2007;45:S229
3. Dolci A, Scapellato L, Infusino I, Panteghini M. Results of the implementation of recommendations for appropriate use of tumor biomarkers (TBM) in a university hospital. Clin Chem Lab Med 2007;45:S343
4. VA Information Resource Center. VIReC unique patient-label frequencies: decision support system laboratory national data extracts June 2009 (Revised March 2010). Hines, IL: US Department of Veterans Affairs, Health Services Research and Development Service. VA Information Resource Center, 2010
5. Medicare Australia. MBS Items Statistics Reports. Canberra: Department of Health of Australia, 2010
6. Fryer AA, Hanna FW. Managing demand for pathology tests: financial imperative or duty of care? Ann Clin Biochem 2009;46:435-7
7. Central Statistics Office. Census 2006 principal demographic results. Cork, Ireland: Central Statistics Office, 2007
8. Watt AM, Hiller JE, Braunack-Mayer AJ, Moss JR, Buchan H, Wale J, et al. The ASTUTE Health study protocol: deliberative stakeholder engagements to inform implementation approaches to healthcare disinvestment. Implement Sci 2012;7:101-12
9. Willis CD, Elshaug AG, Milverton JL, Watt AM, Metz MP, Hiller JE, et al. Diagnostic performance of serum cobalamin tests: A systematic review and meta-analysis. Pathology 2011;43: 472-81
10. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso- Coello P, et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. Br Med J 2008;336:924-6 (Pubitemid 351632017)
11. Szoke D, Panteghini M. Diagnostic value of transferrin. Clin Chim Acta 2012;413:1184-9
12. Yetley EA, Pfeiffer CM, Phinney KW, Bailey RL, Blackmore S, Bock JL, et al. Biomarkers of vitamin B-12 status in NHANES: A roundtable summary. Am J Clin Nutr 2011;94:313S-21S
13. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. Br Med J 1996;312:71-2
14. Reitsma JB, Moons KG, Bossuyt PM, Linnet K. Systematic reviews of studies quantifying the accuracy of diagnostic tests and markers. Clin Chem 2012;58:1534-45
15. Ochodo EA, Bossuyt PM. Reporting the accuracy of diagnostic tests: The STARD initiative 10 years on. Clin Chem 2013;59:917-9
16. Ferraro S, Braga F, Lanzoni M, Boracchi P, Biganzoli EM, Panteghini M. Serum human epididymis protein 4 vs. carbohydrate antigen 125 for ovarian cancer diagnosis: A systematic review. J Clin Pathol 2013;66:273-81
17. EUnetHTA. Work package 4: common core HTA. HTA core model for diagnostic technologies. Availa-comments/EUnetHTACoreModelforDiagnostics2008- 07-15-2.pdf. Accessed 17 May, 2013
18. EUnetHTA. Core model for screening technologies. Available from: http://www.eunethta.eu. Accessed 17 May, 2013
19. ICGB. Policy issues for the development and use of biomarkers in health (2011). Available from: http://www.oecd.org/env/ehs/ biotrack/49867087.pdf. Accessed 17 May, 2013
20. Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, Podell ER, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988;318:1720-8
21. Stabler SP. Vitamin B12 deficiency. N Engl J Med 2013;368: 149-60
22. Carmel R. Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: A critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr 2011;94:348S-58S
23. Andres E, Serraj K. Optimal management of pernicious anemia. J Blood Med 2012;3:97-103
24. Andrès E, Loukili NH, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, et al. Vitamin B12 (cobalamin) deficiency in elderly patients. Can Med Assoc J 2004;171:251-9 (Pubitemid 39061592)
25. Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D'Agostino RB, et al. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham Study. Ann Intern Med 1999;131:352-5 (Pubitemid 29424629)
26. Huang T, Chen Y, Yang B, Yang J, Wahlqvist ML, Li D. Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality. Clin Nutr 2012;31:448-54
27. Mei W, Rong Y, Jinming L, Yongjun L, Hui Z. Effect of homocysteine interventions on the risk of cardiocerebrovascular events: A meta-analysis of randomised controlled trials. Int J Clin Pract 2010;64:208-15
28. McHugh J, Afghan R, O'Brien E, Kennedy P, Leahy M, O'Keeffe D. Impact of the introduction of guidelines on vitamin B12 testing. Clin Chem 2012;58:471-2
29. Dror DK, Allen LH. Effect of vitamin B12 deficiency on neurodevelopment in infants: current knowledge and possible mechanisms. Nutr Rev 2008;66:250-5 (Pubitemid 351623969)
30. Saifan C, Samarneh M, Shtaynberg N, Nasr R, El-Charabaty E, El-Sayegh S. Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen® requirements. Int J Nephrol Renovasc Dis 2013;6:89-93
31. Morkbak AL, Hvas AM, Milman N, Nexo E. Holotranscobalamin remains unchanged during pregnancy. Longitudinal changes of cobalamins and their binding proteins during pregnancy and postpartum. Haematologica 2007;92:1711-2 (Pubitemid 350248256)
32. Chanarin I. The megaloblastic anaemias, 2nd ed. Oxford: Blackwell Scientific Publishing, 1979
33. Snow CF. Laboratory diagnosis of vitamin B12 and folate deficiency: A guide for the primary care physician. Arch Intern Med 1999;159:1289-98 (Pubitemid 29293591)
34. Green R, Kinsella LJ. Current concepts in the diagnosis of cobalamin deficiency. Neurology 1995;45:1435-40
35. Andrès E, Affenberger S, Vinzio S, Noel E, Kaltenbach G, Schlienger JL. Cobalamin deficiencies in adults: update of etiologies, clinical manifestations and treatment. Rev Med Interne 2005;26:938-46 (Pubitemid 41767496)
36. England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, et al. Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009;72: 185-92
37. Institute of Medicine Food and Nutrition Board. Dietary reference intakes: Thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline. Washington, DC: National Academies Press, 1998
38. Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol 1990;34:99-107 (Pubitemid 20180101)
39. American Dietetic Association, Dietitians of Canada. Position of the American Dietetic Association and Dietitians of Canada: vegetarian diets. J Am Diet Assoc 2003;103:748-65
40. Wilson RD, Johnson JA, Wyatt P, Allen V, Gagnon A, Langlois S, et al. Pre-conceptional vitamin/folic acid supplementation 2007: The use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2007;29:1003-26
41. Khoueiry G, Waked A, Goldman M, El-Charabaty E, Dunne E, Smith M, et al. Dietary intake in hemodialysis patients does not reflect a heart healthy diet. J Ren Nutr 2011;21:438-47
42. Herrmann W, Obeid R, Schorr H, Geisel J. Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med 2003;41:1478-88 (Pubitemid 37493564)
43. Watkins D, Rosenblatt DS. Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet 2011;157C:33-44
44. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2 Group. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529-36
45. Lloyd-Wright Z, Hvas AM, Møller J, Sanders TA, Nexo E. Holo-transcobalamin as an indicator of dietary vitamin B12 deficiency. Clin Chem 2003;49:2076-8 (Pubitemid 37449481)
46. Herrmann W, Schorr H, Obeid R, Geisel J. Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians. Am J Clin Nutr 2003;78:131-6 (Pubitemid 39655258)
47. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, et al. Facts and recommendations about total homocysteine determinations: An expert opinion. Clin Chem 2004;50:3-32 (Pubitemid 38125696)
48. Hvas AM, Nexo E. Diagnosis and treatment of vitamin B12 deficiency - an update. Haematologica 2006;91:1506-12 (Pubitemid 44736117)
49. Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood 1990;76:871-81 (Pubitemid 20295496)
50. Volkov I, Rudoy I, Machagna M, Glezer I, Ganel U, Orenshtein A, et al. What are the recommended guidelines for checking vitamin B12 by primary practitioners? Eur J Gen Pract 2007;13:155-6 (Pubitemid 350017984)
51. Lang T. The Association for Clinical Biochemistry and Laboratory Medicine. National minimum re-testing interval project. Prepared for the Clinical Practice Group of the ACB and supported by the Royal College of Pathologists, 2013:1-36
52. Devalia V. Diagnosing vitamin B-12 deficiency on the basis of serum B-12 assay. Br Med J 2006;333:385-6 (Pubitemid 44298067)
53. Goringe A, Ellis R, McDowell I, Vidal-Alaball J, Jenkins C, Butler C, et al. The limited value of methylmalonic acid, homocysteine and holotranscobalamin in the diagnosis of early B12 deficiency. Haematologica 2006;91:231-4
54. Loikas S, Koskinen P, Irjala K, Löppönen M, Isoaho R, Kivelä SL, et al. Renal impairment compromises the use of total homocysteine and methylmalonic acid but not total vitamin B12 and holotranscobalamin in screening for vitamin B12 deficiency in the aged. Clin Chem Lab Med 2007;45: 197-201 (Pubitemid 46294679)
55. Lewerin C, Ljungman S, Nilsson-Ehle H. Glomerular filtration rate as measured by serum cystatin C is an important determinant of plasma homocysteine and serum methylmalonic acid in the elderly. J Intern Med 2007;261:65-73 (Pubitemid 46046473)
56. Tudhope GR, Wilson GM. Deficiency of vitamin B12 in hypothyroidism. Lancet 1962;1:703-6
57. Carmel R, Brar S, Agrawal A, Penha PD. Failure of assay to identify low cobalamin concentrations. Clin Chem 2000;46:2017-8
58. Emancipator K, Mansbach L, Robert T, Waskiewicz D. Failure of assay to identify low cobalamin concentrations. Representatives of bayer diagnostics respond. Clin Chem 2000;46:2018-9
59. Solomon LR. Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing. Blood 2005;105:978-85 (Pubitemid 40170864)
60. Vlasveld LT, van't Wout JW, Meeuwissen P, Castel A. High measured cobalamin (vitamin B12) concentration attributable to an analytical problem in testing serum from a patient with pernicious anemia. Clin Chem 2006;52:157-8 (Pubitemid 43032486)
61. Yetley EA, Johnson CL. Folate and vitamin B-12 biomarkers in NHANES: history of their measurement and use. Am J Clin Nutr 2011;94:322S-31S
62. Hom BL, Olesen HA. Plasma clearance of 57cobalt-labelled vitamin B12 bound in vitro and in vivo to transcobalamin I and II. Scand J Clin Lab Invest 1969;23:201-11
63. Nexo E, Gimsing P. Turnover in humans of iodine- and cobalamin-labeled transcobalamin I and of iodine-labeled albumin. Scand J Clin Lab Invest 1975;35:391-8
64. Nexo E, Hoffmann-Lücke E. Holotranscobalamin, a marker of vitamin B-12 status: Analytical aspects and clinical utility. Am J Clin Nutr 2011;94:359S-65S
65. Nexo E, Christensen AL, Hvas AM, Petersen TE, Fedosov SN. Quantification of holo-transcobalamin, a marker of vitamin B12 deficiency. Clin Chem 2002;48:561-2 (Pubitemid 34174588)
66. Valente E, Scott JM, Ueland PM, Cunningham C, Casey M, Molloy AM. Diagnostic accuracy of holotranscobalamin, methylmalonic acid, serum cobalamin, and other indicators of tissue vitamin B12 status in the elderly. Clin Chem 2011;57:856-63
67. Carmel R. Holotranscobalamin: not ready for prime time. Clin Chem 2012;58:643-5
68. Bock JL, Eckfeldt JH. Advances in standardization of laboratory measurement procedures: implications for measuring biomarkers of folate and vitamin B-12 status in NHANES. Am J Clin Nutr 2011;94:332S-6S
69. Panteghini M. Implementation of standardization in clinical practice: not always an easy task. Clin Chem Lab Med 2012;50:1237-41
70. Thorpe SJ. The development and role of international biological reference materials in the diagnosis of anaemia. Biologicals 2010;38:449-58
71. Development of standard reference materials for vitamins B6 and B12 in human serum. Available from: www.nist.gov/mml/ csd/organic/vitsb6andb12inserum. cfm. Accessed 17 May, 2013
72. Bock JL, Endres DB, Elin RJ, Wang E, Rosenzweig B, Klee GG. Comparison of fresh frozen serum to traditional proficiency testing material in a College of American Pathologists survey for ferritin, folate, and vitamin B12. Arch Pathol Lab Med 2005;129:323-7 (Pubitemid 40343985)
73. Vogeser M, Lorenzl S. Comparison of automated assays for the determination of vitamin B12 in serum. Clin Biochem 2007;40:1342-5 (Pubitemid 47570042)
74. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 2005;82:442-50
75. Pfeiffer CM, Johnson CL, Jain RB, Yetley EA, Picciano MF, Rader JI, et al. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004. Am J Clin Nutr 2007;86: 718-27 (Pubitemid 47435840)
76. Tietz NW. Clinical guide to laboratory tests. Philadelphia, PA: WB Saunders, 1995:636-9
77. Jacobs DS, Kasten BL, Demott WR, Tilzer I. Laboratory test handbook. Hudson, OH: Lexi-Comp, Inc., 1996:350-2
78. Selhub J, Jacques PF, Dallal G, Choumenkovitch S, Rogers G. The use of blood concentrations of vitamins and their respective functional indicators to define folate and vitamin B12 status. Food Nutr Bull 2008;29:S67-73
79. Harris EK. Effects of intra- and inter-individual variation on the appropriate use of normal range. Clin Chem 1974;20:1535-42
80. Lacher DA, Hughes JP, Carroll MD. Biological variation of laboratory analytes based on the 1999-2002 National Health and Nutrition Examination Survey. Natl Health Stat Report 2010;21:1-7
81. Lacher DA, Hughes JP, Carroll MD. Estimate of biological variation of laboratory analytes based on the third National Health and Nutrition Examination Survey. Clin Chem 2005;51:450-2 (Pubitemid 40175818)
82. McKinley MC, Strai JJ, McPartlin JJ, Scott JM, McNulty E. Plasma homocysteine is not subject to seasonal variation. Clin Chem 2001;47:1430-6 (Pubitemid 32678822)
83. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409-37.